Maven Securities »

Acasti Pharma shares owned by Maven Securities

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Maven Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $454k 200k 2.27

More positions owned by Maven Securities

Vaneck Etf Trust Call Call Option
Ishares Tr Call Call Option
Vaneck Etf Trust Put Put Option
State Str Spdr S&p 500 Et F T Put
Microsoft Corp Put Put Option
Invesco Qqq Tr Put Put Option
Micron Technology Call Call Option
Select Sector Spdr Tr Put Put Option
Meta Platforms Put Put Option
Microsoft Corporation (MSFT)
Unitedhealth Group Put Put Option
Select Sector Spdr Tr Call Call Option
Nvidia Corporation Put Put Option
Advanced Micro Devices In C Call
Ishares Tr Put Put Option

View all positions for Maven Securities

Top funds holding Acasti Pharma

HPM Partners
Eversept Partners
Bank of America Corporation
Vanguard Capital Management
Citadel Advisors
Maven Securities
Jane Street
Birchview Capital
Cantor Fitzgerald, L. P.
Two Sigma Investments
XTX Topco
Hrt Financial
Susquehanna International
BlackRock
Rangeley Capital

View all funds holding Acasti Pharma